Showing 475 results

Filters Content type: News, Editors' picks Topic: Treatment guidelines

Expert guidelines, based on research evidence, to help clinicians provide care. They are produced by bodies such as the British HIV Association (BHIVA), the European AIDS Clinical Society (EACS) and the World Health Organization (WHO).

Drug-resistant TB

Rapid communication: Key changes to the treatment of drug-resistant tuberculosis

Editor's pick
World Health Organization
4 May 2022
Coronavirus

Top 5 stories on HIV treatment and care in Africa from CROI 2022

News
1 March 2022
Changing treatment

Further evidence that recycling tenofovir in second-line treatment is effective

News
22 February 2022
Injectable & long-acting HIV treatment

Interim BHIVA guidance on long-acting cabotegravir/rilpivirine (LA-CAB/RPV) for antiretroviral therapy

Editor's pick
BHIVA
7 February 2022
Treatment for women

Large disparities in dolutegravir uptake persist between men and women in low and middle-income countries

News
27 January 2022
Pregnancy and vertical transmission

Updated US Guidelines: TAF In, Cabenuva Out for Pregnant People

Editor's pick
POZ
25 January 2022
Treatment guidelines

Act now to tackle HIV drug resistance, WHO urges

Editor's pick
Avert
10 January 2022
HIV testing policies & guidelines

American Academy of Pediatrics Advises Universal, Routine HIV Screening in Teens and Biomedical HIV Prevention for Youth at Risk

Editor's pick
American Academy of Pediatrics
28 December 2021
Treatment guidelines

Community Position Statement: DRV/r Must Urgently Become the Preferred Protease Inhibitor Used in Adult Second-Line ART

Editor's pick
AfroCAB
6 December 2021
Injectable & long-acting HIV treatment

First injectable therapy for HIV approved for England and Wales

News
18 November 2021
Starting treatment

Dolutegravir more likely to suppress very high viral loads than other recommended first-line drugs

News
14 September 2021
Adherence

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

News
20 August 2021
Injectable & long-acting HIV treatment

New Guideline for Replacement ART: CAB/RPV LA Not for Everyone

Editor's pick
Medscape (requires free registration)
3 August 2021
Treatment guidelines

Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all

News
18 July 2021
Treatment guidelines

WHO publishes new Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring

Editor's pick
World Health Organization
17 July 2021
Treatment guidelines

What's New in U.S. HIV Clinical Treatment Guidelines

Editor's pick
TheBodyPro
17 June 2021
Treatment guidelines

Updates to the Antiretroviral Agents in Adults and Adolescents Living with HIV Guidelines Released

Editor's pick
HIV.gov
7 June 2021
Money

Immediate HIV treatment reduces out-of-pocket health expenditures

News
4 June 2021
Retention & linkage to care

Two times a year is better than four: people spend less time off ART if they only visit their clinic every six months, African study shows

News
17 May 2021
Starting treatment

Same-day ART initiation linked to increased risk of negative outcomes

News
7 May 2021
Treatment guidelines

Updated recommendations on service delivery for the treatment and care of people living with HIV

Editor's pick
World Health Organization
4 May 2021
Treatment guidelines

Top 5 stories on HIV treatment and care in Africa from CROI 2021

News
23 March 2021
Treatment guidelines

WHO publishes new clinical recommendations on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring

Editor's pick
World Health Organization
18 March 2021
Changing treatment

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

News
9 March 2021